All stock lists
Merchants Bancorp (NASDAQ:MBIN)
US · Delayed Price · Currency is USD
Financial Services · Banks - Regional
49.80+0.82 (+1.68%)
Market cap
$2.29B
Health Score
Analyst consensus
Listed since
Oct 27, 2017
Website
Insider Score
––Not scored
MBIN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
MBIN analyst forecast
MBIN analyst consensus
Moderate Buy2 ratings
Buy 1 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
MBIN 12-month price target
$63.00+27.0% upsideaverage of 1 firm
$63.00High
$63.00Low
Best analysts covering MBIN
- Raymond James56%success rate · 16 calls
- Piper Sandler44%success rate · 9 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
MBIN analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Piper Sandler | Overweight | $63.00 | +26.1% | Reiterated | 2026-10-05 | |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-09-08 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-07-29 |
| — | Raymond James | Market Perform | — | — | Downgraded | 2026-07-01 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-06-29 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-03-02 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-01-30 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-10-30 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-10-29 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-09-29 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-07-30 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-07-29 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-07-29 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-04-29 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-04-02 |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2025-03-13 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-01-30 |
| — | Raymond James | Outperform | — | — | Reiterated | 2025-01-30 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-11-26 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-10-30 |
| — | Raymond James | Outperform | — | — | Reiterated | 2024-10-29 |
| — | Raymond James | Outperform | — | — | Downgraded | 2024-07-30 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-05-17 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2024-05-15 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-05-03 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2024-01-30 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-10-30 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2023-07-31 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-07-31 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2023-05-01 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-02-28 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2023-01-31 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-10-06 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2022-09-28 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-08-01 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2022-05-02 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2021-11-02 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2021-08-26 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2021-02-01 |
| — | Raymond James | Strong Buy | — | — | Reiterated | 2020-12-07 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2020-09-29 |
| — | Truist Securities | Buy | — | — | Reiterated | 2020-08-25 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2020-07-29 |
| — | SunTrust Robinson Humphrey | Buy | — | — | Reiterated | 2020-05-19 |
| — | Raymond James | Outperform | — | — | Reiterated | 2020-02-03 |
| — | Raymond James | Outperform | — | — | Reiterated | 2019-08-29 |
| — | Stephens & Co. | Equal Weight | — | — | Downgraded | 2018-07-11 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2017-11-21 |
| — | Raymond James | Outperform | — | — | Reiterated | 2017-11-21 |
| — | SunTrust Robinson Humphrey | Buy | — | — | Reiterated | 2017-11-21 |
| — | Sandler O'Neill | Buy | — | — | Reiterated | 2017-11-21 |
MBIN earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-01-28 | 0.94 | 1.28 | $170.8M | $185.3M |
| 2026-04-28 | 1.16 | 1.25 | $174.3M | $175.2M |
| 2026-07-28 | 1.22 | 1.48 | $179.0M | $182.2M |
| 2026-10-28 | 1.39 | 0.00 | $182.9M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.